1. Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors

   • Susan J. Hines
   • Julie S. Litz
   • Geoffrey W. Krystal

   OriginalPaper Pages: 1 - 10

2. BRCA1 mutation testing for Japanese patients with ovarian cancer in breast cancer screening

   • Yoichiro Yamashita
   • Tadashi Sagawa
   • Seiichiro Fujimoto

   OriginalPaper Pages: 11 - 17

3. Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions

   • Maresa Altomonte
   • Ester Fonsatti
   • Michele Maio

   OriginalPaper Pages: 19 - 23

4. p73 mutations are not detected in sporadic and hereditary breast cancer

   • David I. Schwartz
   • Noralane M. Lindor
   • Fergus J. Couch

   OriginalPaper Pages: 25 - 29

5. Policy guidelines for the utilization of formalin-fixed, paraffin-embedded tissue sections: the UNC SPORE experience

   • L.G. Dressler
   • J. Geradts
   • B. Newman

   OriginalPaper Pages: 31 - 39

6. Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family

   • Søren S. Larsen
   • Mikala Egeblad
   • Anne E. Lykkesfeldt

   OriginalPaper Pages: 41 - 56

7. Local signals induce CCAAT/enhancer binding protein-δ (C/EBP-δ) and C/EBP-β mRNA expression in the involuting mouse mammary gland

   • Andrew P. Gigliotti
   • James W. DeWille

   OriginalPaper Pages: 57 - 63

8. Telomerase activity in ductal carcinoma in situ of the breast

   • B. Shpitz
   • S. Zimlichman
   • A.pitz Klein

   OriginalPaper Pages: 65 - 69

9. Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice

   • D. Arndt
   • R. Zeisig
   • A. Fahr

   OriginalPaper Pages: 71 - 80

10. Breast Cancer Research and Treatment

    • Michele Alexander

    OriginalPaper Pages: 81 - 85